CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction

PHASE3CompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

January 31, 2010

Conditions
Myocardial Infarction
Interventions
DRUG

Clopidogrel (Iscover/Plavix)

Pre-hospital loading-dose of 600 mg Clopidogrel as early as possible

Trial Locations (25)

10365

Sana Klinikum Lichtenberg / Oskar-Ziethen-Krankenhaus, Berlin

12200

Universitaetsklinikum Benjamin Franklin, Berlin

12351

Vivantes Klinikum Neukoelln, Berlin

13187

Maria Heimsuchung / Caritas-Klinik Pankow, Berlin

14050

DRK-Kliniken Westend, Berlin

14770

Staedtisches Klinikum, Brandenburg

16909

KMG-Kliniken AG / Klinikum Wittstock, Wittstock

18057

Universitaetsklinikum Rostock, Rostock

21339

Städtisches Klinikum, Lüneburg

29223

Allgemeines Krankenhaus, Celle

35392

Universitaetsklinikum Giessen, Giessen

37603

Evangelisches Krankenhaus, Holzminden

51375

Klinikum Leverkusen, Leverkusen

60590

Klinikum der Johann-Wolfgang-Goethe Universitaet, Frankfurt am Main

61231

Kerckhoff Klinik, Bad Nauheim

64283

Klinikum Darmstadt, Darmstadt

64646

Kreiskrankenhaus Bergstrasse, Heppenheim an der Bergstrasse

65549

St. Vincenz-Krankenhaus, Limburg an der Lahn

66119

Klinikum Saarbruecken, Saarbrücken

67063

Klinikum der Stadt Ludwigshafen, Med. Klinik B, Ludwigshafen am Rhein

68167

Universitaetsklinikum Mannheim, Mannheim

A-6020

Universitaetsklinikum Innsbruck, Innsbruck

A-1140

Hanusch-Krankenhaus, Vienna

A-1171

Wilhelminenspital, Vienna

04289

Universitaet Leipzig - Herzzentrum, Leipzig

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

Stiftung Institut fuer Herzinfarktforschung

OTHER

NCT00372216 - CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter